advanced search

Welcome: Guest

log in

United Kingdom Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2012

Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 157
ISBN Number not applicable
Product Code GMD04588
Price

£1,960.00
approximately: $2,997 | €2,186

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

This report is an essential source for in-depth information and data relating to the UK Endoscopy Devices devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the Endoscopy Devices in UK

Scope

  • The report provides endoscopy devices information broken down into detailed categories and segments in United Kingdom.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the endoscopy devices market in United Kingdom.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Content

  • 1 Table Of Contents
  • 1 Table Of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Endoscopy Devices
        • 2.2.1.1 Flexible Endoscope
        • 2.2.1.2 Rigid Endoscope
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Sector Review
    • 3.2 Healthcare Expenditure
    • 3.3 Healthcare Infrastructure
    • 3.4 Healthcare Policy
  • 4 Endoscopy Devices in United Kingdom
    • 4.1 Endoscopy Devices Overall Revenues (2000-2012)
    • 4.2 Endoscopy Devices Overall Volume (2000-2012)
    • 4.3 Endoscopy Devices Overall Company Share (2006-2007)
  • 5 Flexible Endoscope in United Kingdom
    • 5.1 Flexible Endoscope Overall Revenue (2000-2012)
    • 5.2 Flexible Endoscope Overall Volume (2000-2012)
    • 5.3 Flexible Endoscope Average Price (2000-2012)
    • 5.4 Flexible Endoscope Distribution Share (2006-2007)
    • 5.5 Flexible Endoscope Company Share (2006-2007)
  • 6 Rigid Endoscope in United Kingdom
    • 6.1 Rigid Endoscope Overall Revenues (2000-2012)
    • 6.2 Rigid Endoscope Overall Volume (2000-2012)
    • 6.3 Rigid Endoscope Average Price (2000-2012)
    • 6.4 Rigid Endoscope Distribution Share (2006-2007)
    • 6.5 Rigid Endoscope Company Share (2006-2007)
  • 7 OLYMPUS CORPORATION Company Profile
    • 7.1 Company Overview
    • 7.2 Business Overview
      • 7.2.1 Imaging Systems Business
        • 7.2.1.1 Overview
        • 7.2.1.2 Financials
        • 7.2.1.3 Capital Expenditure
        • 7.2.1.4 Market View
        • 7.2.1.5 Key Strategies
      • 7.2.2 Information and Communication Business
        • 7.2.2.1 Overview
        • 7.2.2.2 Financials
        • 7.2.2.3 Capital Expenditure
        • 7.2.2.4 Key Strategies
      • 7.2.3 Life Sciences Business
        • 7.2.3.1 Overview
        • 7.2.3.2 Financials
        • 7.2.3.3 Capital Expenditure
        • 7.2.3.4 Market View
        • 7.2.3.5 Key Strategies
      • 7.2.4 Medical Systems Business
        • 7.2.4.1 Overview
        • 7.2.4.2 Financials
        • 7.2.4.3 Capital Expenditure
        • 7.2.4.4 Market View
        • 7.2.4.5 Key Strategies
      • 7.2.5 Others
        • 7.2.5.1 Overview
        • 7.2.5.2 Financials
        • 7.2.5.3 Capital Expenditure
        • 7.2.5.4 Market View
        • 7.2.5.5 Key Strategies
      • 7.2.6 Major Products and Services
      • 7.2.7 History
    • 7.3 Value Chain Analysis
      • 7.3.1 Manufacturing
        • 7.3.1.1 In House Manufacturing
      • 7.3.2 Product Development
        • 7.3.2.1 Regulatory Approvals
        • 7.3.2.2 Research and Development
      • 7.3.3 Sales and Marketing
        • 7.3.3.1 Partnerships and Alliances
        • 7.3.3.2 Licensing Agreements
        • 7.3.3.3 E-distribution
    • 7.4 SWOT Analysis
      • 7.4.1 OLYMPUS CORPORATION Strengths
        • 7.4.1.1 Expansion of business activities
        • 7.4.1.2 Strong internal control system
        • 7.4.1.3 Strong financial performance
      • 7.4.2 OLYMPUS CORPORATION Weaknesses
        • 7.4.2.1 Sluggish growth in Imaging Systems Business division
        • 7.4.2.2 Weak presence in Asia
        • 7.4.2.3 Inconsistent profit margin
      • 7.4.3 OLYMPUS CORPORATION Opportunities
        • 7.4.3.1 Focused R&D
        • 7.4.3.2 Launching of new products
        • 7.4.3.3 Expansion of global markets
      • 7.4.4 OLYMPUS CORPORATION Threats
        • 7.4.4.1 Price competition
        • 7.4.4.2 Dependent on key suppliers
        • 7.4.4.3 Pricing pressures in Japan
    • 7.5 Revenue Analysis
      • 7.5.1 Revenue by Segment
      • 7.5.2 Revenue by Geography
    • 7.6 Financial and Operational Review
      • 7.6.1 Financial Statements
      • 7.6.2 Financial Ratios
      • 7.6.3 Share Holding Structure
    • 7.7 Locations And Subsidiaries
    • 7.8 Financial Deals Landscape
      • 7.8.1 Spiration Secures $18.5 Million In Series G Round Of Financing
      • 7.8.2 Terumo Forms Joint Venture With Olympus Corporation
      • 7.8.3 Olympus Signs An Agreement With Visen Medical
      • 7.8.4 Olympus Acquires Stake In Cytori Therapeutics
      • 7.8.5 Olympus Corporation Forms A Joint Venture With Movaz Networks
      • 7.8.6 Spiration Secures $13.4 Million In Series F Financing
      • 7.8.7 Olympus Corporation Forms Partnership With Takano
      • 7.8.8 Olympus To Acquire Gyrus Group
    • 7.9 Recent Developments
      • 7.9.1 Apr 01, 2008: Olympus Appoints New CEO
      • 7.9.2 Feb 04, 2008: Olympus Reports Q3 Fiscal 2008 Results
      • 7.9.3 Nov 06, 2007: Olympus Reports Q2 Fiscal 2008 Results
      • 7.9.4 Jul 30, 2007: Olympus Reports Q1 Fiscal 2008 Results
      • 7.9.5 Jul 30, 2007: Olympus Reports H1 Fiscal 2006 Results
      • 7.9.6 Jul 30, 2007: Olympus Reports Q1 Fiscal 2006 Results
      • 7.9.7 Jul 30, 2007: Olympus Reports Fiscal 2006 Results
      • 7.9.8 Jul 30, 2007: Olympus Reports Q3 Fiscal 2006 Results
      • 7.9.9 Jul 30, 2007: Olympus Reports Q1 Fiscal 2007 Results
      • 7.9.10 May 08, 2007: Olympus Reports Fiscal 2007 Results
      • 7.9.11 Feb 05, 2007: Olympus Reports Q3 Fiscal 2007 Results
    • 7.10 OLYMPUS CORPORATION Pipeline Products
      • 7.10.1 OLYMPUS CAPSULE ENDOSCOPE SYSTEM
        • 7.10.1.1 Product Overview
        • 7.10.1.2 Product Description
        • 7.10.1.3 Product Status
      • 7.10.2 Single Balloon Enteroscopy (SBE) system
        • 7.10.2.1 Product Overview
        • 7.10.2.2 Product Description
        • 7.10.2.3 Product Status
        • 7.10.2.4 Product Milestone
  • 8 KARL STORZ GmbH & Co. KG Company Profile
    • 8.1 Company Overview
    • 8.2 Business Overview
      • 8.2.1 Major Products and Services
      • 8.2.2 History
    • 8.3 Locations And Subsidiaries
    • 8.4 Financial Deals Landscape
      • 8.4.1 KARL STORZ Signs An Agreement With EndoGastric Solutions
  • 9 PENTAX Medical Company Profile
    • 9.1 Company Overview
    • 9.2 Business Overview
      • 9.2.1 Major Products and Services
      • 9.2.2 History
    • 9.3 Locations And Subsidiaries
    • 9.4 Financial Deals Landscape
      • 9.4.1 PENTAX Medical Company Acquires Operating Assets Of KayPENTAX (formerly Kay Elemetrics)
    • 9.5 Recent Developments
      • 9.5.1 Oct 06, 2007: PENTAX Appoints VP, Sales And Marketing
  • 10 B. Braun Melsungen AG Company Profile
    • 10.1 Company Overview
    • 10.2 Business Overview
      • 10.2.1 Aesculap division
        • 10.2.1.1 Overview
        • 10.2.1.2 Financials
        • 10.2.1.3 Market View
        • 10.2.1.4 Key Strategies
      • 10.2.2 B. Braun Avitum division
        • 10.2.2.1 Overview
        • 10.2.2.2 Financials
        • 10.2.2.3 Market View
        • 10.2.2.4 Key Strategies
      • 10.2.3 Hospital Care division
        • 10.2.3.1 Overview
        • 10.2.3.2 Financials
        • 10.2.3.3 Key Strategies
      • 10.2.4 Out Patient Market (OPM) division
        • 10.2.4.1 Overview
        • 10.2.4.2 Financials
        • 10.2.4.3 Market View
        • 10.2.4.4 Key Strategies
      • 10.2.5 Major Products and Services
      • 10.2.6 History
    • 10.3 Value Chain Analysis
      • 10.3.1 Manufacturing
        • 10.3.1.1 In House Manufacturing
        • 10.3.1.2 Outsourcing
      • 10.3.2 Product Development
        • 10.3.2.1 Regulatory Approvals
        • 10.3.2.2 Clinical Trials
        • 10.3.2.3 Research and Development
      • 10.3.3 Sales and Marketing
        • 10.3.3.1 Partnerships and Alliances
        • 10.3.3.2 Licensing Agreements
    • 10.4 SWOT Analysis
      • 10.4.1 B. Braun Melsungen AG Strengths
        • 10.4.1.1 L.I.F.E certification
        • 10.4.1.2 Significant revenues
        • 10.4.1.3 Worldwide existence
      • 10.4.2 B. Braun Melsungen AG Weaknesses
        • 10.4.2.1 High SG&A expenses
        • 10.4.2.2 FDA warning letter
      • 10.4.3 B. Braun Melsungen AG Opportunities
        • 10.4.3.1 Acquisitions
        • 10.4.3.2 Expansion of business
        • 10.4.3.3 Broad product portfolio
      • 10.4.4 B. Braun Melsungen AG Threats
        • 10.4.4.1 Foreign exchange
        • 10.4.4.2 Intense competition and change in technologies
    • 10.5 Revenue Analysis
      • 10.5.1 Revenue by Segment
      • 10.5.2 Revenue by Geography
    • 10.6 Financial and Operational Review
      • 10.6.1 Financial Statements
      • 10.6.2 Financial Ratios
    • 10.7 Locations And Subsidiaries
    • 10.8 Financial Deals Landscape
      • 10.8.1 B. Braun Signs An Agreement With Nipro
      • 10.8.2 B. Braun Enters Into A Licensing Agreement With Chartie Hospital
      • 10.8.3 B. Braun Signs An Agreement With Charite
    • 10.9 Recent Developments
      • 10.9.1 Mar 26, 2008: B. Braun Reports 2007 Results
      • 10.9.2 Oct 25, 2007: B. Braun Melsungen Signs Distribution Agreement With NIPRO
      • 10.9.3 May 25, 2007: B. Braun Melsungen Enters Into Strategic Alliance With Health Robotics
      • 10.9.4 Mar 28, 2007: B. Braun Melsungen Reports 2006 Results
      • 10.9.5 Mar 24, 2007: B. Braun Melsungen To Shut Its Plant In Puerto Rico
      • 10.9.6 Mar 15, 2007: B. Braun Melsungen To Invest In Medical Technology Production
      • 10.9.7 Sep 19, 2005: B. Braun Medical Opens Manufacturing Facility In Suzhou
    • 10.10 B. Braun Melsungen AG Pipeline Products
      • 10.10.1 Coroflex Please
        • 10.10.1.1 Product Overview
        • 10.10.1.2 Product Description
        • 10.10.1.3 Product Status
        • 10.10.1.4 Product Milestone
      • 10.10.2 SeQuent Please
        • 10.10.2.1 Product Overview
        • 10.10.2.2 Product Description
        • 10.10.2.3 Product Status
  • 11 Fujinon Corporation Company Profile
    • 11.1 Company Overview
    • 11.2 Business Overview
      • 11.2.1 Major Products and Services
      • 11.2.2 History
    • 11.3 Locations And Subsidiaries
    • 11.4 Financial Deals Landscape
      • 11.4.1 Given Imaging And Fujinon Corporation Sign Global Strategic Collaboration
    • 11.5 Recent Developments
      • 11.5.1 Jul 11, 2006: Fujinon Reports Fiscal 2007 Results
  • 12 Regulation System
    • 12.1 Medical Equipment Approval Process
      • 12.1.1 Classification of Medical Devices
      • 12.1.2 Conformity Assessment Process
        • 12.1.2.1 Class I devices
        • 12.1.2.2 Class IIa devices
        • 12.1.2.3 Class IIb devices
        • 12.1.2.4 Class III devices
    • 12.2 Medical Device approval fee
    • 12.3 Post Market Surveillance (PMS)
  • 13 Pricing and Reimbursement
    • 13.1 Market Pricing
    • 13.2 Government Policies for Reimbursement
  • 14 Distribution Structure
  • 15 APPENDIX
    • 15.1 Global Markets Direct Research Methodology
    • 15.2 Coverage
    • 15.3 Secondary Research
    • 15.4 Primary Research
    • 15.5 Models
    • 15.6 Forecasts
    • 15.7 Expert Panels
    • 15.8 Currency Conversion
    • 15.9 Contact Us
    • 15.10 Disclaimer
  • LIST OF TABLES
  • List of Tables
    • Table 1: Number of Doctor by Specialty in UK, 2003 - 2007
    • Table 2: Endoscopy Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Table 3: Endoscopy Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 4: Endoscopy Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 5: Endoscopy Devices, United Kingdom, Category Revenues ($ mn), 2000-2012
    • Table 6: Endoscopy Devices, United Kingdom, Category Revenues ($ mn), Historic, 2000-2007
    • Table 7: Endoscopy Devices, United Kingdom, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 8: Endoscopy Devices, United Kingdom, Category Volume (Units), 2000-2012
    • Table 9: Endoscopy Devices, United Kingdom, Category Volume (Units), Historic, 2000-2007
    • Table 10: Endoscopy Devices, United Kingdom, Category Volume (Units), Forecast, 2007-2012
    • Table 11: Endoscopy Devices, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 12: Flexible Endoscope, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 13: Flexible Endoscope, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 14: Flexible Endoscope, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 15: Flexible Endoscope, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 16: Flexible Endoscope, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 17: Flexible Endoscope, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 18: Flexible Endoscope, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 19: Flexible Endoscope, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 20: Rigid Endoscope, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 21: Rigid Endoscope, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 22: Rigid Endoscope, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Table 23: Rigid Endoscope, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Table 24: Rigid Endoscope, United Kingdom, Average Price ($), Historic, 2000-2007
    • Table 25: Rigid Endoscope, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Table 26: Rigid Endoscope, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 27: Rigid Endoscope, United Kingdom, Company Share by Revenue ($ mn), 2006-2007
    • Table 28: OLYMPUS CORPORATION, SWOT Analysis, 2007
    • Table 29: OLYMPUS CORPORATION, Revenue by Segment, Yen Million, 2003-2007
    • Table 30: OLYMPUS CORPORATION, Revenue by Geography, Yen Million, 2003-2007
    • Table 31: OLYMPUS CORPORATION, Financial Statements, Yen Million, 2003-2007
    • Table 32: OLYMPUS CORPORATION, Financial Ratios, Yen Million, 2003-2007
    • Table 33: OLYMPUS CORPORATION, Share Holding Structure
    • Table 34: OLYMPUS CORPORATION, Other Locations
    • Table 35: OLYMPUS CORPORATION, Other Locations(Contd..)
    • Table 36: OLYMPUS CORPORATION, Subsidiaries
    • Table 37: KARL STORZ GmbH & Co. KG, Other Locations
    • Table 38: KARL STORZ GmbH & Co. KG, Other Locations(Contd..)
    • Table 39: PENTAX Medical Company, Other Locations
    • Table 40: B. Braun Melsungen AG, SWOT Analysis, 2006
    • Table 41: B. Braun Melsungen AG, Revenue by Segment, Euro Thousand, 2002-2006
    • Table 42: B. Braun Melsungen AG, Revenue by Geography, Euro Thousand, 2002-2006
    • Table 43: B. Braun Melsungen AG, Financial Statements, Euro Thousand, 2002-2006
    • Table 44: B. Braun Melsungen AG, Financial Ratios, Euro Thousand, 2002-2006
    • Table 45: B. Braun Melsungen AG, Subsidiaries
    • Table 46: B. Braun Melsungen AG, Subsidiaries(Contd..)
    • Table 47: Fujinon Corporation, Subsidiaries
    • Table 48: Medical Device Approval Fee in UK, 2006
    • Table 49: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • LIST OF FIGURES
  • List of Figures
    • Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006
    • Figure 2: Endoscopy Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012
    • Figure 3: Endoscopy Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 4: Endoscopy Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 5: Endoscopy Devices, United Kingdom, Category Revenues ($ mn), 2000-2012
    • Figure 6: Endoscopy Devices, United Kingdom, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 7: Endoscopy Devices, United Kingdom, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 8: Endoscopy Devices, United Kingdom, Category Volume (Units), 2000-2012
    • Figure 9: Endoscopy Devices, United Kingdom, Category Volume (Units), Historic, 2000-2007
    • Figure 10: Endoscopy Devices, United Kingdom, Category Volume (Units), Forecast, 2007-2012
    • Figure 11: Endoscopy Devices, United Kingdom, Company Share (%), 2007
    • Figure 12: Flexible Endoscope, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 13: Flexible Endoscope, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 14: Flexible Endoscope, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 15: Flexible Endoscope, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 16: Flexible Endoscope, United Kingdom, Average Price ($), Historic, 2000-2007
    • Figure 17: Flexible Endoscope, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Figure 18: Flexible Endoscope, United Kingdom, Distribution Share (%), 2007
    • Figure 19: Flexible Endoscope, United Kingdom, Company Share (%), 2007
    • Figure 20: Rigid Endoscope, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 21: Rigid Endoscope, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 22: Rigid Endoscope, United Kingdom, Overall Volume (Units), Historic, 2000-2007
    • Figure 23: Rigid Endoscope, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
    • Figure 24: Rigid Endoscope, United Kingdom, Average Price ($), Historic, 2000-2007
    • Figure 25: Rigid Endoscope, United Kingdom, Average Price ($), Forecast, 2007-2012
    • Figure 26: Rigid Endoscope, United Kingdom, Distribution Share (%), 2007
    • Figure 27: Rigid Endoscope, United Kingdom, Company Share (%), 2007
    • Figure 28: OLYMPUS CORPORATION, Value Chain Analysis
    • Figure 29: B. Braun Melsungen AG, Value Chain Analysis
    • Figure 30: Flowchart for Classification of Non-invasive Devices in UK, 2007
    • Figure 31: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 32: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 33: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 34: Flowchart for Classification of Invasive Devices in UK, 2007
    • Figure 35: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 36: Flowchart for Classification of Active Devices in UK, 2007
    • Figure 37: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007
    • Figure 38: Conformity Assessment of Class-I Medical Devices in UK, 2007
    • Figure 39: Conformity Assessment of Class-IIa Medical Devices in UK, 2007
    • Figure 40: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
    • Figure 41: Conformity Assessment of Class-III Medical Devices in UK, 2007
    • Figure 42: Global Markets Direct Methodology